Volatile organic compound breath signatures of children with cystic fibrosis by real-time SESI-HRMS Source: ERJ Open Res, 6 (1) 00171-2019; 10.1183/23120541.00171-2019 Year: 2020
Determination of volatile organic compounds in exhaled breath of patients with chronic obstructive pulmonary disease by gas chromatography mass spectrometry Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease Year: 2010
Ionic composition of exhaled breath condenesate in cystic fibrosis Source: Eur Respir J 2001; 18: Suppl. 33, 8s Year: 2001
Exhaled pentane – a new breath test in cystic fibrosis? Source: Annual Congress 2006 - New developments in infant and intensive care lung function Year: 2006
Analysis of semi-volatile organic compounds in exhaled breath condensate of patients with obstructive lung diseases Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities Year: 2010
Exhaled breath analysis by ion mobility spectrometry in children with asthma and cystic fibrosis Source: International Congress 2018 – Cystic fibrosis in paediatric patients: current research Year: 2018
Detection of elevated 2-propanol in breath samples from children with cystic fibrosis Source: Eur Respir J 2006; 28: Suppl. 50, 309s Year: 2006
Diagnostic potential of organic halides as breath biomarkers in cystic fibrosis Source: Annual Congress 2007 - Clinical outcome studies and technical aspects of paediatric lung function testing Year: 2007
NO metabolites in exhaled breath condensate in cystic fibrosis patients: correlation with pulmonary function, nutritional status and systemic inflammation Source: Eur Respir J 2006; 28: Suppl. 50, 715s Year: 2006
Conductivity in exhaled breath condensate of patients with asthma, COPD or cystic fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 227s Year: 2005
Volatile organic compounds (VOC) in exhaled breath of patients with COPD Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases Year: 2010
Volatile organic compounds (VOC) in exhaled breath in patients with lung cancer, using the analytical technique thermal desorber- gase chromatography-spectrometer mases Source: Annual Congress 2012 - New biomarkers for lung cancer Year: 2012
Nitrogen multiple breath washout test for infants with cystic fibrosis Source: Eur Respir J, 52 (2) 1800015; 10.1183/13993003.00015-2018 Year: 2018
Cytokines in exhaled breath condensate of children with asthma and cystic fibrosis Source: Eur Respir J 2004; 24: Suppl. 48, 468s Year: 2004
Exhaled air molecular profiling in relation to inflammatory subtype and activity in COPD Source: Eur Respir J 2011; 38: 1301-1309 Year: 2011
Prediction of CF exacerbations in children by exhaled inflammation markers Source: International Congress 2015 – Cystic fibrosis: physiology, biomarkers, microbiology and miscellaneous Year: 2015
Volatile organic compounds in exhaled breath are associated with exacerbations in children with asthma Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma Year: 2009
Influence of salivary nitrite on levels in exhaled breath condensate in patients with cystic fibrosis Source: Eur Respir J 2006; 28: Suppl. 50, 715s Year: 2006
Inflammatory markers in exhaled breath condensate, assessed by means of Luminex® technology, can differentiate between children with asthma, cystic fibrosis and healthy controls Source: Annual Congress 2007 - Bronchiolitis - viruses, treatment and outcome Year: 2007
The relationship between CT assessed lung damage, and inflammatory markers in exhaled breath condensate of cystic fibrosis patients Source: Annual Congress 2007 - Cystic fibrosis lung disease: what do we measure? What do we know? Year: 2007